vs
Live Nation Entertainment（LYV）与Stryker Corporation（SYK）财务数据对比。点击上方公司名可切换其他公司
Stryker Corporation的季度营收约是Live Nation Entertainment的1.1倍（$7.2B vs $6.3B），Stryker Corporation净利率更高（11.8% vs -3.2%，领先15.0%），Stryker Corporation同比增速更快（11.4% vs 11.1%），Stryker Corporation自由现金流更多（$1.9B vs $-405.6M），过去两年Live Nation Entertainment的营收复合增速更高（28.9% vs 16.9%）
Live Nation Entertainment是美国跨国娱乐企业，2010年由Live Nation与Ticketmaster合并成立，旗下保留运营两大原有品牌。公司业务覆盖全球，主营现场娱乐活动宣发、票务销售，同时持有并运营多家娱乐场馆，还为音乐人提供艺人经纪管理服务。
斯特赖克是一款八轮装甲战车，衍生自加拿大LAV III步兵战车，而后者源自瑞士莫瓦格食人鱼系列装甲车。该型战车由加拿大通用动力陆地系统公司为美国陆军生产，制造工厂位于安大略省伦敦市。它默认采用8×4四轮驱动，可切换为8×8全轮驱动模式。
LYV vs SYK — 直观对比
营收规模更大
SYK
是对方的1.1倍
$6.3B
营收增速更快
SYK
高出0.3%
11.1%
净利率更高
SYK
高出15.0%
-3.2%
自由现金流更多
SYK
多$2.3B
$-405.6M
两年增速更快
LYV
近两年复合增速
16.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $6.3B | $7.2B |
| 净利润 | $-202.1M | $849.0M |
| 毛利率 | — | 64.5% |
| 营业利润率 | -2.3% | 25.2% |
| 净利率 | -3.2% | 11.8% |
| 营收同比 | 11.1% | 11.4% |
| 净利润同比 | -204.6% | 55.5% |
| 每股收益（稀释后） | $-1.06 | $2.20 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LYVSYK
| Q4 25 | $6.3B | $7.2B | ||
| Q3 25 | $8.5B | $6.1B | ||
| Q2 25 | $7.0B | $6.0B | ||
| Q1 25 | $3.4B | $5.9B | ||
| Q4 24 | $5.7B | $6.4B | ||
| Q3 24 | $7.7B | $5.5B | ||
| Q2 24 | $6.0B | $5.4B | ||
| Q1 24 | $3.8B | $5.2B |
净利润LYVSYK
| Q4 25 | $-202.1M | $849.0M | ||
| Q3 25 | $431.5M | $859.0M | ||
| Q2 25 | $243.4M | $884.0M | ||
| Q1 25 | $23.2M | $654.0M | ||
| Q4 24 | $193.2M | $546.0M | ||
| Q3 24 | $451.8M | $834.0M | ||
| Q2 24 | $298.0M | $825.0M | ||
| Q1 24 | $-46.7M | $788.0M |
毛利率LYVSYK
| Q4 25 | — | 64.5% | ||
| Q3 25 | — | 63.6% | ||
| Q2 25 | — | 63.8% | ||
| Q1 25 | — | 63.8% | ||
| Q4 24 | — | 64.9% | ||
| Q3 24 | — | 64.0% | ||
| Q2 24 | — | 63.0% | ||
| Q1 24 | — | 63.6% |
营业利润率LYVSYK
| Q4 25 | -2.3% | 25.2% | ||
| Q3 25 | 9.3% | 18.7% | ||
| Q2 25 | 6.9% | 18.5% | ||
| Q1 25 | 3.4% | 14.3% | ||
| Q4 24 | -4.3% | 9.0% | ||
| Q3 24 | 8.4% | 19.7% | ||
| Q2 24 | 7.7% | 19.4% | ||
| Q1 24 | -1.0% | 18.5% |
净利率LYVSYK
| Q4 25 | -3.2% | 11.8% | ||
| Q3 25 | 5.1% | 14.2% | ||
| Q2 25 | 3.5% | 14.7% | ||
| Q1 25 | 0.7% | 11.1% | ||
| Q4 24 | 3.4% | 8.5% | ||
| Q3 24 | 5.9% | 15.2% | ||
| Q2 24 | 4.9% | 15.2% | ||
| Q1 24 | -1.2% | 15.0% |
每股收益（稀释后）LYVSYK
| Q4 25 | $-1.06 | $2.20 | ||
| Q3 25 | $0.73 | $2.22 | ||
| Q2 25 | $0.41 | $2.29 | ||
| Q1 25 | $-0.32 | $1.69 | ||
| Q4 24 | $0.58 | $1.41 | ||
| Q3 24 | $1.66 | $2.16 | ||
| Q2 24 | $1.03 | $2.14 | ||
| Q1 24 | $-0.53 | $2.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.1B | $4.0B |
| 总债务越低越好 | $7.6B | — |
| 股东权益账面价值 | $271.0M | $22.4B |
| 总资产 | $22.9B | $47.8B |
| 负债/权益比越低杠杆越低 | 28.09× | — |
8季度趋势，按日历期对齐
现金及短期投资LYVSYK
| Q4 25 | $7.1B | $4.0B | ||
| Q3 25 | $6.8B | $3.3B | ||
| Q2 25 | $7.1B | $2.4B | ||
| Q1 25 | $7.2B | $2.3B | ||
| Q4 24 | $6.1B | $3.7B | ||
| Q3 24 | $5.5B | $3.9B | ||
| Q2 24 | $6.4B | $1.9B | ||
| Q1 24 | $6.5B | $2.3B |
总债务LYVSYK
| Q4 25 | $7.6B | — | ||
| Q3 25 | $6.1B | — | ||
| Q2 25 | $5.0B | — | ||
| Q1 25 | $5.9B | — | ||
| Q4 24 | $6.2B | — | ||
| Q3 24 | $5.7B | — | ||
| Q2 24 | $5.1B | — | ||
| Q1 24 | $5.1B | — |
股东权益LYVSYK
| Q4 25 | $271.0M | $22.4B | ||
| Q3 25 | $521.3M | $21.8B | ||
| Q2 25 | $360.1M | $21.2B | ||
| Q1 25 | $106.0M | $20.9B | ||
| Q4 24 | $173.3M | $20.6B | ||
| Q3 24 | $288.0M | $20.1B | ||
| Q2 24 | $-43.3M | $19.8B | ||
| Q1 24 | $-114.8M | $19.2B |
总资产LYVSYK
| Q4 25 | $22.9B | $47.8B | ||
| Q3 25 | $22.9B | $47.1B | ||
| Q2 25 | $23.2B | $46.3B | ||
| Q1 25 | $21.8B | $46.0B | ||
| Q4 24 | $19.6B | $43.0B | ||
| Q3 24 | $19.7B | $43.8B | ||
| Q2 24 | $20.5B | $39.1B | ||
| Q1 24 | $20.0B | $39.4B |
负债/权益比LYVSYK
| Q4 25 | 28.09× | — | ||
| Q3 25 | 11.71× | — | ||
| Q2 25 | 13.86× | — | ||
| Q1 25 | 55.93× | — | ||
| Q4 24 | 35.65× | — | ||
| Q3 24 | 19.70× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-53.7M | $2.1B |
| 自由现金流经营现金流 - 资本支出 | $-405.6M | $1.9B |
| 自由现金流率自由现金流/营收 | -6.4% | 26.1% |
| 资本支出强度资本支出/营收 | 5.6% | 3.7% |
| 现金转化率经营现金流/净利润 | — | 2.52× |
| 过去12个月自由现金流最近4个季度 | $333.6M | $4.3B |
8季度趋势，按日历期对齐
经营现金流LYVSYK
| Q4 25 | $-53.7M | $2.1B | ||
| Q3 25 | $-95.7M | $1.5B | ||
| Q2 25 | $223.5M | $1.1B | ||
| Q1 25 | $1.3B | $250.0M | ||
| Q4 24 | $1.0B | $1.9B | ||
| Q3 24 | $-720.9M | $1.5B | ||
| Q2 24 | $412.1M | $633.0M | ||
| Q1 24 | $988.9M | $204.0M |
自由现金流LYVSYK
| Q4 25 | $-405.6M | $1.9B | ||
| Q3 25 | $-371.3M | $1.4B | ||
| Q2 25 | $-39.9M | $928.0M | ||
| Q1 25 | $1.2B | $127.0M | ||
| Q4 24 | $890.2M | $1.7B | ||
| Q3 24 | $-879.0M | $1.3B | ||
| Q2 24 | $212.4M | $481.0M | ||
| Q1 24 | $854.8M | $37.0M |
自由现金流率LYVSYK
| Q4 25 | -6.4% | 26.1% | ||
| Q3 25 | -4.4% | 22.3% | ||
| Q2 25 | -0.6% | 15.4% | ||
| Q1 25 | 34.0% | 2.2% | ||
| Q4 24 | 15.7% | 25.9% | ||
| Q3 24 | -11.5% | 23.7% | ||
| Q2 24 | 3.5% | 8.9% | ||
| Q1 24 | 22.5% | 0.7% |
资本支出强度LYVSYK
| Q4 25 | 5.6% | 3.7% | ||
| Q3 25 | 3.2% | 3.1% | ||
| Q2 25 | 3.8% | 3.0% | ||
| Q1 25 | 5.0% | 2.1% | ||
| Q4 24 | 2.7% | 4.1% | ||
| Q3 24 | 2.1% | 3.1% | ||
| Q2 24 | 3.3% | 2.8% | ||
| Q1 24 | 3.5% | 3.2% |
现金转化率LYVSYK
| Q4 25 | — | 2.52× | ||
| Q3 25 | -0.22× | 1.79× | ||
| Q2 25 | 0.92× | 1.26× | ||
| Q1 25 | 56.94× | 0.38× | ||
| Q4 24 | 5.41× | 3.54× | ||
| Q3 24 | -1.60× | 1.77× | ||
| Q2 24 | 1.38× | 0.77× | ||
| Q1 24 | — | 0.26× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LYV
| Concerts | $5.1B | 82% |
| Ticketing | $846.2M | 13% |
| Sponsorship And Advertising | $329.9M | 5% |
SYK
| Medical | $1.3B | 18% |
| Endoscopy | $1.1B | 16% |
| Traumaand Extremities | $1.1B | 15% |
| Instruments | $925.0M | 13% |
| Knees | $749.0M | 10% |
| Neuro Cranial | $669.0M | 9% |
| Neurovascular | $539.0M | 8% |
| Hips | $499.0M | 7% |
| Other Orthopaedics | $267.0M | 4% |
| Spine | $8.0M | 0% |
